COLLEGE
04/21/2010 05:12 am ET Updated May 25, 2011

UKansas Develops New Ovarian Cancer Drug

The University of Kansas Cancer Center began running a Phase I clinical trial of the anti-ovarian cancer drug Nanotax. Nanotax is a breakthrough drug because, unlike other anti-cancer drugs, it is water-soluble.

Read more on The Daily Kansan

Subscribe to the Lifestyle email.
Life hacks and juicy stories to get you through the week.